Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Iranian future healthcare professionals' knowledge and opinions about rare diseases: cross-sectional study.
Jahanshahi R, Nasirzadeh A, Farzan M, Domaradzki J, Jouybari L, Sanagoo A, Farzan M, Aghazadeh-Habashi K, Fallah Faraghe A, Bagheri S, Samiee M, Ansari A, Eskandari K, Namakkoobi N, Soltanimoghadam F, Mashali H, Yavari E, Bay S, Memaripanah N, Meftah E, Amanzadeh S, Talati F, Bahramzadeh S. Jahanshahi R, et al. Among authors: nasirzadeh a. Orphanet J Rare Dis. 2022 Sep 29;17(1):366. doi: 10.1186/s13023-022-02458-8. Orphanet J Rare Dis. 2022. PMID: 36175905 Free PMC article.
A double-blind, controlled, crossover trial of amlodipine on iron overload status in transfusion dependent β-thalassemia patients.
Karami H, Khalilzadeh Arjmandi H, Salehifar E, Darvishi-Khezri H, Dabirian M, Kosaryan M, Aliasgharian A, Akbarzadeh R, Naeimayi Aali R, Nasirzadeh A. Karami H, et al. Among authors: nasirzadeh a. Int J Clin Pract. 2021 Aug;75(8):e14337. doi: 10.1111/ijcp.14337. Epub 2021 May 24. Int J Clin Pract. 2021. PMID: 33969592 Clinical Trial.
Coadministration of silymarin with iron chelators in transfusion-dependent β-thalassemia patients: a systematic review and meta-analysis for effect on iron overload.
Darvishi-Khezri H, Naderisorki M, Zahedi M, Mortazavi P, Tajik F, Nasirzadeh A, Karami H. Darvishi-Khezri H, et al. Among authors: nasirzadeh a. Expert Rev Clin Pharmacol. 2021 Nov;14(11):1445-1453. doi: 10.1080/17512433.2021.1964953. Epub 2021 Sep 6. Expert Rev Clin Pharmacol. 2021. PMID: 34486906